Diffuse large B-cell lymphoma trials in Switzerland
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Baden, Bellinzona, Lugano, Sankt Gallen
- Age
- 18 years and over
- People
- 1,046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347 · EU 2024-515566-13-00 - No phaseTaking peopleLiquid Biopsy in Mature B-cell Tumors
- Where
- Bellinzona
- Age
- 18 years and over
- People
- 444
- Run by
- Oncology Institute of Southern Switzerland
See details and how to joinNCT03280394 - Phase 1Taking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Basel, Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
- Age
- 18 years and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - No phaseNot yet taking people in SwitzerlandCharacterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
- Where
- Bellinzona
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- International Extranodal Lymphoma Study Group (IELSG)
See details and how to joinNCT07147751 - Phase 1/2Taking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Sankt Gallen
- Age
- 18 years and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394